Bio-Conjugated Advanced Materials for Targeted Disease Theranostics

Xi Le Hu; Nahyun Kwon; Kai Cheng Yan; Adam C. Sedgwick; Guo Rong Chen; Xiao Peng He; Tony D. James; Juyoung Yoon

doi:10.1002/adfm.201907906

Bio-Conjugated Advanced Materials for Targeted Disease Theranostics

Xi Le Hu, Nahyun Kwon, Kai Cheng Yan, Adam C. Sedgwick, Guo Rong Chen, Xiao Peng He, Tony D. James, Juyoung Yoon

Research output: Contribution to journal › Review article › peer-review

67 Citations (SciVal)

Abstract

Human beings are “machines” that use endogenously produced biomolecules as “components” in signaling and for the maintenance of the body. These biomolecules consist of proteins, nucleic acids, and carbohydrates, which can either be extracted from biological substrates or synthesized by chemical/biochemical methods. These biomolecules have the ability to recognize/interact with other biomolecules that are overexpressed in disease cells. For targeted theranostics, strategies to chemically incorporate these natural biomolecules with advanced materials to treat human diseases by imaging-guided drug delivery or photodynamic/photothermal therapy are proposed, with improved biocompatibility. Herein, recent research on construction of quantum dots, nanoparticles, and 2D material platforms decorated with antibodies, peptides, nucleic acid aptamers, carbohydrates, and folic acid for targeted diagnosis and treatment are summarized and discussed. In addition, the various strategies required to construct effective functional materials for targeted cancer therapy are highlighted. The hope is that this review can inspire and guide those that are interested in the field of biomedicine to rationally design and develop new target-based theranostic materials.

Original language	English
Article number	1907906
Journal	Advanced Functional Materials
Volume	30
Issue number	13
Early online date	3 Feb 2020
DOIs	https://doi.org/10.1002/adfm.201907906
Publication status	Published - 24 Mar 2020

Bibliographical note

Funding Information:
X.-L.H. and N.K. contributed equally to this work. The authors thank the Natural Science Foundation of China (Nos. 21788102, 91853201, 21722801, and 21776078), the Shanghai Municipal Science and Technology Major Project (No. 2018SHZDZX03), The National Key Sci-Tech Special Projects of Infection Diseases of China (2018ZX10732202) and the Shanghai Science and Technology Committee (No. 19410712600). J.Y. thanks the National Research Foundation of Korea (NRF), which was funded by the Korea government (MSIP) (No. 2012R1A3A2048814). T.D.J. thanks the Royal Society for a Wolfson Research Merit Award.

Publisher Copyright:
© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim

Keywords

advanced materials
aptamers
biomolecules
peptides
theranostics

ASJC Scopus subject areas

General Chemistry
General Materials Science
Condensed Matter Physics

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/adfm.201907906

Cite this

@article{1bcc850ecbfb483392803dd99106df77,

title = "Bio-Conjugated Advanced Materials for Targeted Disease Theranostics",

abstract = "Human beings are “machines” that use endogenously produced biomolecules as “components” in signaling and for the maintenance of the body. These biomolecules consist of proteins, nucleic acids, and carbohydrates, which can either be extracted from biological substrates or synthesized by chemical/biochemical methods. These biomolecules have the ability to recognize/interact with other biomolecules that are overexpressed in disease cells. For targeted theranostics, strategies to chemically incorporate these natural biomolecules with advanced materials to treat human diseases by imaging-guided drug delivery or photodynamic/photothermal therapy are proposed, with improved biocompatibility. Herein, recent research on construction of quantum dots, nanoparticles, and 2D material platforms decorated with antibodies, peptides, nucleic acid aptamers, carbohydrates, and folic acid for targeted diagnosis and treatment are summarized and discussed. In addition, the various strategies required to construct effective functional materials for targeted cancer therapy are highlighted. The hope is that this review can inspire and guide those that are interested in the field of biomedicine to rationally design and develop new target-based theranostic materials.",

keywords = "advanced materials, aptamers, biomolecules, peptides, theranostics",

author = "Hu, {Xi Le} and Nahyun Kwon and Yan, {Kai Cheng} and Sedgwick, {Adam C.} and Chen, {Guo Rong} and He, {Xiao Peng} and James, {Tony D.} and Juyoung Yoon",

note = "Funding Information: X.-L.H. and N.K. contributed equally to this work. The authors thank the Natural Science Foundation of China (Nos. 21788102, 91853201, 21722801, and 21776078), the Shanghai Municipal Science and Technology Major Project (No. 2018SHZDZX03), The National Key Sci-Tech Special Projects of Infection Diseases of China (2018ZX10732202) and the Shanghai Science and Technology Committee (No. 19410712600). J.Y. thanks the National Research Foundation of Korea (NRF), which was funded by the Korea government (MSIP) (No. 2012R1A3A2048814). T.D.J. thanks the Royal Society for a Wolfson Research Merit Award. Publisher Copyright: {\textcopyright} 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim",

year = "2020",

month = mar,

day = "24",

doi = "10.1002/adfm.201907906",

language = "English",

volume = "30",

journal = "Advanced Functional Materials",

issn = "1616-301X",

publisher = "Wiley-VCH Verlag",

number = "13",

}

TY - JOUR

T1 - Bio-Conjugated Advanced Materials for Targeted Disease Theranostics

AU - Hu, Xi Le

AU - Kwon, Nahyun

AU - Yan, Kai Cheng

AU - Sedgwick, Adam C.

AU - Chen, Guo Rong

AU - He, Xiao Peng

AU - James, Tony D.

AU - Yoon, Juyoung

N1 - Funding Information: X.-L.H. and N.K. contributed equally to this work. The authors thank the Natural Science Foundation of China (Nos. 21788102, 91853201, 21722801, and 21776078), the Shanghai Municipal Science and Technology Major Project (No. 2018SHZDZX03), The National Key Sci-Tech Special Projects of Infection Diseases of China (2018ZX10732202) and the Shanghai Science and Technology Committee (No. 19410712600). J.Y. thanks the National Research Foundation of Korea (NRF), which was funded by the Korea government (MSIP) (No. 2012R1A3A2048814). T.D.J. thanks the Royal Society for a Wolfson Research Merit Award. Publisher Copyright: © 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim

PY - 2020/3/24

Y1 - 2020/3/24

N2 - Human beings are “machines” that use endogenously produced biomolecules as “components” in signaling and for the maintenance of the body. These biomolecules consist of proteins, nucleic acids, and carbohydrates, which can either be extracted from biological substrates or synthesized by chemical/biochemical methods. These biomolecules have the ability to recognize/interact with other biomolecules that are overexpressed in disease cells. For targeted theranostics, strategies to chemically incorporate these natural biomolecules with advanced materials to treat human diseases by imaging-guided drug delivery or photodynamic/photothermal therapy are proposed, with improved biocompatibility. Herein, recent research on construction of quantum dots, nanoparticles, and 2D material platforms decorated with antibodies, peptides, nucleic acid aptamers, carbohydrates, and folic acid for targeted diagnosis and treatment are summarized and discussed. In addition, the various strategies required to construct effective functional materials for targeted cancer therapy are highlighted. The hope is that this review can inspire and guide those that are interested in the field of biomedicine to rationally design and develop new target-based theranostic materials.

AB - Human beings are “machines” that use endogenously produced biomolecules as “components” in signaling and for the maintenance of the body. These biomolecules consist of proteins, nucleic acids, and carbohydrates, which can either be extracted from biological substrates or synthesized by chemical/biochemical methods. These biomolecules have the ability to recognize/interact with other biomolecules that are overexpressed in disease cells. For targeted theranostics, strategies to chemically incorporate these natural biomolecules with advanced materials to treat human diseases by imaging-guided drug delivery or photodynamic/photothermal therapy are proposed, with improved biocompatibility. Herein, recent research on construction of quantum dots, nanoparticles, and 2D material platforms decorated with antibodies, peptides, nucleic acid aptamers, carbohydrates, and folic acid for targeted diagnosis and treatment are summarized and discussed. In addition, the various strategies required to construct effective functional materials for targeted cancer therapy are highlighted. The hope is that this review can inspire and guide those that are interested in the field of biomedicine to rationally design and develop new target-based theranostic materials.

KW - advanced materials

KW - aptamers

KW - biomolecules

KW - peptides

KW - theranostics

UR - http://www.scopus.com/inward/record.url?scp=85078853522&partnerID=8YFLogxK

U2 - 10.1002/adfm.201907906

DO - 10.1002/adfm.201907906

M3 - Review article

AN - SCOPUS:85078853522

SN - 1616-301X

VL - 30

JO - Advanced Functional Materials

JF - Advanced Functional Materials

IS - 13

M1 - 1907906

ER -

Bio-Conjugated Advanced Materials for Targeted Disease Theranostics

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this